From 28 percent to 68 percent of women using hormones at menopause take compounded, so-called ‘bioidentical’ hormones, but women don’t understand the risks of these unapproved, untested treatments, shows an analysis of two large surveys.
From 28 percent to 68 percent of women using hormones at menopause take compounded, so-called ‘bioidentical’ hormones, but women don’t understand the risks of these unapproved, untested treatments, shows an analysis of two large surveys.